By Andrea Figueras Shares in Idorsia tumbled on Tuesday after the company suspended its target of becoming profitable in 2025, citing a slower-than-expected.
^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating businesses in the Asia Pacific (ex-China) region ("Territory"), including assignment of PIVLAZ (clazosentan) and license rights to daridorexant in .
10.07.2023 - Ad hoc announcement pursuant to Art. 53 LR The approximately 20 million US lives covered by CVS will now have easier and more affordable access to QUVIVIQ Allschwil, Switzerland & Radnor, PA, United States – July 10, 2023Idorsia Ltd (SIX: . Seite 1
Citigroup began coverage on shares of Idorsia (OTCMKTS:IDRSF – Free Report) in a report issued on Thursday morning, FlyOnTheWall reports. The firm issued a sell rating on the stock. Several other research firms also recently weighed in on IDRSF. Morgan Stanley assumed coverage on shares of Idorsia in a report on Thursday, June 22nd. They […]
^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - June 06, 2023 Idorsia Ltd (SIX: IDIA) today announced that it has entered into exclusive negotiations with an undisclosed party regarding its operating businesses in the Asia Pacific (ex-China) region, including selected licens.